Position in BFRI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$148,999
+$130,580 QoQ
Shares Held
157,505
+742.3% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 19 holders
Holding Since
Sep 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BFRI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $2,242,924,243 across 49 Drug Manufacturers - Specialty & Generic names. BFRI ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,708,739 | $925,846,052 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
2,335,897 | $393,692,080 | |
| 3 | ALKS |
Alkermes plc.
|
6,460,928 | $338,552,627 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
7,347,028 | $106,458,435 | |
| 5 | ZTS |
Zoetis Inc.
|
1,403,300 | $100,841,138 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,478,180 | $68,750,151 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,366,549 | $49,469,073 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
1,733,801 | $43,986,531 |
All Filings in BFRI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,999 | 157,505 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $18,419 | 18,700 | Shares | Sole | 2025-11-13 | |
| 2024-03-31 | $15,740 | 10,221 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $26,225 | 50,434 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $21,797 | 35,734 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $18,279 | 19,934 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,630 | 13,934 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||